D&D Pharmatech 17% surge · L&C Bio 5% rise, as biotech companies continue attending U.S. events

D&D Pharmatech 2026 year 6 month 17 day, its stock surged % after news emerged that it was pursuing joint development with LG. The company disclosed that related discussions were underway.17The company disclosed that related discussions were underway.

L&C Bio's stock rose % on the same day on news related to hair-loss treatment using a skin booster. The company said it was reviewing the product's potential applications.5L&C Bio's stock rose % on the same day on news related to hair-loss treatment using a skin booster. The company said it was reviewing the product's potential applications.

GemVax 2026 year 6 month 17 day disclosed that it had appointed former Gyeonggi Province Governor Nam Kyung-pil as chairman. The company said it would disclose the background to his appointment and its future plans.

Dong-A Socio Group announced that it would participate in 2026 year 6 month’s BIO USA to explore business opportunities. The purpose of its participation is to identify overseas partners and discuss technology cooperation.

OliX said it would hold discussions on technology licensing and research and development at the same event. The company left open the possibility of partnership negotiations.

Alginomics announced that it would participate in 2026 year 6 month 16 day’s BIO USA to hold partnership discussions. The announcement did not disclose the specific parties to the negotiations.

Several South Korean biotechnology companies are participating in the event simultaneously and have successively issued disclosures and carried out activities related to technology licensing and partnerships. Each company said it would make additional disclosures on the results going forward.